KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Moderna (MRNA) Short-term Investments: 2017-2025

Historic Short-term Investments for Moderna (MRNA) over the last 8 years, with Sep 2025 value amounting to $3.4 billion.

  • Moderna's Short-term Investments fell 35.44% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year decrease of 35.44%. This contributed to the annual value of $5.1 billion for FY2024, which is 10.51% down from last year.
  • Latest data reveals that Moderna reported Short-term Investments of $3.4 billion as of Q3 2025, which was down 12.46% from $3.9 billion recorded in Q2 2025.
  • In the past 5 years, Moderna's Short-term Investments registered a high of $6.7 billion during Q4 2022, and its lowest value of $2.3 billion during Q1 2021.
  • Its 3-year average for Short-term Investments is $5.0 billion, with a median of $5.1 billion in 2024.
  • Its Short-term Investments has fluctuated over the past 5 years, first soared by 177.61% in 2021, then plummeted by 35.91% in 2025.
  • Quarterly analysis of 5 years shows Moderna's Short-term Investments stood at $3.9 billion in 2021, then soared by 72.65% to $6.7 billion in 2022, then dropped by 14.93% to $5.7 billion in 2023, then decreased by 10.51% to $5.1 billion in 2024, then slumped by 35.44% to $3.4 billion in 2025.
  • Its Short-term Investments stands at $3.4 billion for Q3 2025, versus $3.9 billion for Q2 2025 and $4.4 billion for Q1 2025.